Remarkably, ACT of Ptpn22–/– memory phenotype T cells, 24 days prior to tumor challenge, completely prevented the development of EL4-OVA-T4 tumors in 100% of mice tested (Figure 6, B and C, 13 of 13 mice in 2 experiments). The gene discussed is PTPN22; the disease is neoplasm.